Taiwan FDA registration ccd647bc405d77cce7769c3467976d4a
Uco 2nd generation blood glucose test tablets
TW: 優克糖2代 血糖試片
Taiwan·Risk Class 2·Broadcom Biotechnology Co., Ltd.;; Huiyuan Biotechnology Co., Ltd·Registered Nov 07, 2014 – Nov 07, 2019CancelledRegistration details
- Analysis ID
- ccd647bc405d77cce7769c3467976d4a
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- EUMED BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- This product must be used with a Ucosa blood glucose meter for the detection of whole blood glucose concentration at the fingertip. This system is suitable for diabetic patients to self-monitor their blood glucose at home, and can also be used as a blood glucose test for patients in hospitals or clinics.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- Nov 07, 2014
- Expiry Date
- Nov 07, 2019
- Cancellation Date
- Jun 22, 2022
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Uco 2nd generation blood glucose test tablets in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ccd647bc405d77cce7769c3467976d4a and manufactured by Broadcom Biotechnology Co., Ltd.;; Huiyuan Biotechnology Co., Ltd. The authorized representative in Taiwan is EUMED BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices